You reviewed ....
for this content
out of 5
Event : Heart Failure 2018
Topic : Acute Heart Failure
The usefulness of the MEESSI score for risk stratification of patients with acute heart failure at the emergency department: validation in a new Spanish cohort.
Heart Failure 2018
New renal hemodynamic indices can predict worsening of renal function in acute decompensated heart failure
Bio-adrenomedullin is strongly related to congestion and poor outcome in patients with worsening heart failure
Prognostic importance of serum chloride concentration in patients hospitalized due to worsening heart failure
Catheter-based enhancement of lymphatic drainage in fluid overloaded acute decompensated heart failure: First in human experience
The effect of trigger on the prognosis of patients with heart failure and atrial fibrillation: tachycardia-mediated acute decompensation
Long-term (10-year) outcomes of patients admitted with decompensated heart failure in a tertiary care centre in India.
Five-year follow-up in patients with peripartum cardiomyopathy (PPCM) shows high and stable recovery rate and longterm use of cardiovascular medication
Time trends in characteristics, clinical course and outcomes of an unselected sample of 13,791 Spanish patients with acute heart failure (2007-2016)
Clinical manifestations and outcome of acute heart failure in Chagas cardiomyopathy patients in comparison do other etiologies: results of the I Brazilian Heart Failure Registry
30-Day mortality in the takotsubo syndrome compared to acute coronary syndromes
The perceived difficulty of identifying acute heart failure in dispatch centre and by emergency medical services on scene compared to other critical medical conditions
Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care
The relationship between peripartum cardiomyopathy with age and other risk factors
Economic impact of intermittent intravenous outpatient treatment with levosimendan in patients with advanced heart failure
Get your access to resources
Our mission: To reduce the burden of cardiovascular disease